Form 10-Q · Quarterly report
Expedia Group 10-Q, filed Aug 6, 2026
- Filed
- CIK
- 0001324424
- Accession no.
- 0001324424-26-000053
Summary
Expedia Group reported second-quarter 2026 revenue of $4.32 billion, up from $3.79 billion in the same quarter of 2025, with net income attributable to the company of $878 million, or $7.16 per diluted share, versus $330 million and $2.48 a year earlier. For the first six months of 2026, revenue was $7.74 billion and net income attributable to Expedia Group was $872 million, or $7.05 per diluted share, and the company held $6.68 billion in cash and cash equivalents as of June 30, 2026.
Key points
- Second-quarter 2026 revenue was $4,315 million, compared with $3,786 million for the three months ended June 30, 2025.
- Second-quarter 2026 operating income was $800 million, compared with $485 million a year earlier.
- Six-month 2026 revenue was $7,741 million and net income attributable to Expedia Group was $872 million, compared with revenue of $6,774 million and net income of $130 million in the first half of 2025.
- Deferred merchant bookings rose to $15,426 million at June 30, 2026 from $10,428 million at December 31, 2025.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3 Quantitative and Qualitative Disclosures about Market Risk 34 Item 4 Controls and Procedures 35 Part II Other Information Item 1 Legal Proceedings 36 Item 1A Risk Factors 37 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 37 Item 5 Other Information 37 Item 6 Exhibits 38 Signature 39 Table of Contents Part I. Item 1. Consolidated Financial Statements EXPEDIA GROUP, INC. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.